Exchange: NASDAQ·Updated 07:17 PM EDT
DYAI logo

DYAI Dyadic International Inc., DE

$0.4105
$0.003
(0.75%)
Today
Closed $0.399
$0.0115
(2.88%)
After Hours
EarningsNov 11
Mkt Cap$15.99M
Vol40,826.00

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
45

Neutral Sentiment

How do you feel about DYAI?

FinanceLegacy
$DYAI super thin nice volume so far 13G is huge 8.35% stake watch the push with $ESLA same theme👆🏼
2
FinanceLegacy
$DYAI picking up let’s see the breakout over .50 massive 13G these are squeezing potential off $DRMA $ESLA
2
akts
$DYAI coming into year end tax loss selling season in November. If no money comes in before that, this get halved in share price. If Emelfarb doesn’t give them a loan by Jan/Feb, it’s lights out. The likelihood of them getting what they need, in time, is slim. Let’s see if Emelfarb is willing to bet on his own company…..
focafoca99
$DYAI warns it received a Nasdaq deficiency notice for bid price and market value, giving until March 24, 2027 to regain compliance.

Advertisement|Remove ads.